CARDIFF ONCOLOGY, INC. — Net Income by Fiscal Year
26 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38d90745-3f0f-446d-af51-c61926c39e84/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-45.9k | 2025-01-01 – 2025-12-31 | evidence 0001213037-26-000006 |
| FY 2024 | $-45.4k | 2024-01-01 – 2024-12-31 | evidence 0001213037-26-000006 |
| FY 2023 | $-41.4k | 2023-01-01 – 2023-12-31 | evidence 0001213037-26-000006 |
| FY 2022 | $-38.7M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-006037 |
| FY 2021 | $-28.3M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-003808 |
| FY 2020 | $-19.3M | 2020-01-01 – 2020-12-31 | evidence 0001628280-22-003808 |
| FY 2019 | $-16.4M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002424 |
| FY 2018 | $-16.5M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002546 |
| FY 2017 | $-24.9M | 2017-01-01 – 2017-12-31 | evidence 0001628280-18-002226 |
| FY 2016 | $-39.2M | 2016-01-01 – 2016-12-31 | evidence 0001628280-17-002601 |
| FY 2015 | $-27.5M | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-012562 |
| FY 2014 | $-14.3M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-019213 |
| FY 2013 | $-68.6M | 1999-08-04 – 2014-03-31 | evidence 0001104659-14-037604 |
| FY 2012 | $-54.7M | 1999-08-04 – 2013-03-31 | evidence 0001104659-13-041327 |
| FY 2011 | $-43.2M | 1999-08-04 – 2012-03-31 | evidence 0001104659-12-037472 |
| FY 2010 | $-5.4M | 2010-01-01 – 2010-12-31 | evidence 0001104659-12-037472 |
| FY 2009 | $-2.5M | 2009-01-01 – 2009-12-31 | evidence 0001104659-12-037472 |
| FY 2008 | $-5.2M | 2008-01-01 – 2008-12-31 | evidence 0001104659-12-037472 |
| FY 2007 | $-4.7M | 2007-02-01 – 2007-12-31 | evidence 0001104659-12-037472 |
| FY 2006 | $-7.1M | 2006-02-01 – 2007-01-31 | evidence 0001104659-12-037472 |
| FY 2005 | $-7.8M | 2005-02-01 – 2006-01-31 | evidence 0001104659-12-037472 |
| FY 2004 | $-5.4M | 2004-02-01 – 2005-01-31 | evidence 0001104659-12-037472 |
| FY 2003 | $-383.0k | 2003-02-01 – 2004-01-31 | evidence 0001104659-12-037472 |
| FY 2002 | $-481.6k | 2002-02-01 – 2003-01-31 | evidence 0001104659-12-037472 |
| FY 2001 | $-524.2k | 2001-02-01 – 2002-01-31 | evidence 0001104659-12-037472 |
| FY 2000 | $-267.6k | 2000-02-01 – 2001-01-31 | evidence 0001104659-12-037472 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CARDIFF ONCOLOGY, INC. — all facts · Revenue · Operating Income